Ann: ResAppDx receives regulatory approval in Indonesia, page-24

Yes OCYC - this does look exciting but I find it perplexing that the trials are being done in USA and India - why isn’t a trial being conducted here. -
- Better control of how test is conducted
- Can instantly modify Algorithm if needed
- Have more control of the hospitals used and the patients tested
- Would be cheaper to run
- Results faster and Prof here to oversee
- Importantly know what to expect before trialling In other countries - a bad result will be hard to come back from.

- I feel we are going about this the wrong way - we don’t have anyone in these countries to oversee and look what happened to our FDA trials - I hope I am wrong but TK should explain his reasononing. AIMO